Skip to content

Clinical trials

Completed Macular Degeneration trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Status: Completed Country / region: United States Clear all

319 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20024
20039
20049
200511
200613
200723
200821
200912
201020
201110
201223
20138
201417
201520
201611
201711
201815
201918
202017
20217
202210
20236
20245
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed319

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)41
Novartis Pharmaceuticals17
Allergan10
GlaxoSmithKline9
Regeneron Pharmaceuticals8
Duke University6
Johns Hopkins University6
Notal Vision Ltd.6
Oregon Health and Science University5
Wills Eye5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration319
Choroidal Neovascularization48
Geographic Atrophy33
Diabetic Retinopathy25
Retinal Vein Occlusion17
Retinal Degeneration16
Retinal Diseases16
Wet Macular Degeneration16
Eye Diseases15
Macular Edema15

Trials

Showing 1 to 25 of 319. Each trial links to its page on Pharma Observatory.

219 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.